日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial

经动脉化疗栓塞联合卡瑞利珠单抗和利沃西拉尼治疗不可切除的肝细胞癌(CHANCE2005/CARES-005):一项随机II期试验

Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun

UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis.

肝细胞中UFMylation缺乏会激活KEAP1-NRF2通路,并促进肝癌的发生。

Liang Qian, Xu Shiwen, Fang Yaoyao, Wang Xue, Xiao Yang, Wang Yiwen, Li Shujuan, Guo Qifan, Cao Yu, Cao Ying, Liu Chao, Zhao Yuqin, Luo Yan, Wu Anqi, Wang Miao, Shi Junping, Li Guoqing, Cong Yu-Sheng

Hepatocyte SAMHD1 Deficiency Attenuates Hepatic Steatosis via Suppression of SREBP Activation in a Mouse Model of Metabolic-Associated Steatotic Liver Disease.

在代谢相关脂肪肝疾病小鼠模型中,肝细胞 SAMHD1 缺乏通过抑制 SREBP 激活来减轻肝脂肪变性。

Yin Guangfa, Liu Yongqing, Teng Xianhe, Sun Shuqi, Chen Beibei, Wang Xinyu, Yang Tao, Wang Ying, Xu Hanyang, Chen Yu-Sheng, Gan Guowei, Shen Yuxian, Shao Juntang

Altering the Fluorination Anodization Pathway of Silicon Near an Electrolyte Freezing Point Promotes the Formation of Blue-Photoluminescent Microstructures

改变硅在电解液冰点附近的氟化阳极氧化路径可促进蓝光致发光微结构的形成

Chiou, Yu-Sheng; Cheng, Chao-Chia; Li, Ryan Wen-Shuo; Lee, Benjamin Tien-Hsi

Hidden in plain sight: commonly used copper N-heterocyclic carbene catalysts gain stabilization from anagostic Cu⋯H-C interactions

显而易见的秘密:常用的铜-N-杂环卡宾催化剂通过Cu⋯HC相互作用获得稳定性。

Yan, Connly; Chang, Tieyan; Chen, Yu-Sheng; Paterson, Alexander L; McElheny, Dan; Mankad, Neal P

Aging and increased cancer risk: exploring the potential of LE8 score to mitigate risk

衰老与癌症风险增加:探索LE8评分降低风险的潜力

Li, Jiehui; Zhang, Yuhan; Zhang, Wenxing; Zheng, Jiabin; Yu, Sheng; Jiang, Zhuosheng; Huang, Yiqin; Guo, Xin; Xi, Zhihui; Li, Yong; Feng, Huolun

IFI204-STING drives protective innate immunity against gangrenous Clostridium perfringens infection via regulation of NLRP3 signaling.

IFI204-STING 通过调节 NLRP3 信号传导驱动对坏疽性产气荚膜梭菌感染的保护性先天免疫。

Zhang Ming-Yue, Li Jia-Qi, Xu Qian, Zhuang Zi-Jian, Liang Jing, He Ao-Bo, Zhang Shu-Xin, Zhao Yi, Chen Xue, Li Zhen-Yu, Sheng Ping, Liu Yang, Yu Shui-Xing

ClC-3 mediates angiotensin II-induced endothelial dysfunction by inhibiting Akt-Hsp90-eNOS signaling pathway

ClC-3通过抑制Akt-Hsp90-eNOS信号通路介导血管紧张素II诱导的内皮功能障碍

Li, Lei; Lin, Yu-Quan; Peng, Yu-Sheng; Chen, Huan-Hao; Wu, Xiao-Jun; Liang, Guozheng; Du, Yan-Hua

Precision Channel Engineering of Nanotube-Embedded Organic Electrochemical Transistors for Ultrasensitive Neurofilament Light Chain Detection

用于超灵敏神经丝轻链检测的纳米管嵌入式有机电化学晶体管的精密通道工程

She, Jia-Wei; Lin, Lu-An; Aerathupalathu Janardhanan, Jayakrishnan; Wang, I-Chen; Hsu, Feng-Chen; Tseng, Hsueh-Sheng; Hsiao, Yu-Sheng; Yu, Hsiao-Hua

Comparing the expression patterns and differences of LOX and LOXL1 during the development of myodural bridge and ligamentum flavum.

比较肌硬膜桥和黄韧带发育过程中 LOX 和 LOXL1 的表达模式和差异。

Sun Yi-Tong, Li Zhao-Ran, Lai Hua-Xun, Ma Wei, Li Chan, Li Ji-Hang, Chi Yan-Yan, Yu Sheng-Bo, Zheng Nan, Liu Bo, Zhang Jian-Fei, Sui Hong-Jin